Oncology Injectables Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2023-28

1
Global Oncology Injectables Market Research and
Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Oncology Injectables Market Research
Report The latest report by IMARC, titled
Oncology Injectables Market Global Industry
Trends, Share, Size, Growth, Opportunity and
Forecast 2023-2028 the global oncology
injectables market is expected to exhibit a
growth rate (CAGR) of 10.8 during 2023-2028.
Oncology injectables are intravenous drugs that
are widely used for the treatment of different
forms of cancer. These drugs are administered
directly in the bloodstream of the patient to
improve its biological effect. Extensively
available in liquid form, these injectables aid
in mitigating the growth of cancer-inducing
proteins while destroying the malignant cells
formed in the body. These drugs are usually
preferred by healthcare professionals for cancer
treatments as they provide improved efficiency,
increased bioavailability, better compliance and
reduced gastrointestinal irritation. Request
Free Sample Report https//www.imarcgroup.com/onc
ology-injectables-market/requestsample
4
Report Description and Highlights
Report Description

Global Oncology Injectables Market Trends The
market is primarily driven by the increasing
prevalence of various forms of cancer across the
globe. This, along with the growing awareness
regarding early cancer detection among the
masses, is providing a thrust to the market
growth. This is further supported by the easy
accessibility to chemotherapy treatments and
improving healthcare infrastructure on the global
level. There has been a significant increase in
the investments by drug manufacturers and
biotechnology companies for developing new
anti-cancer intravenous drugs, which is acting as
another major growth-inducing factor. These
injectables are expected to be highly efficient
and target-oriented with minimal side effects.
This, coupled with the faster drug approvals
from several regulatory bodies, including the US
Food and Drug Administration (FDA), is
anticipated to create a positive outlook for the
market. Moreover, the growing preference for
multiple generic oncology injectables by patients
on account of the cost-efficient nature of these
drugs is providing an impetus to the market
growth. Some of the other factors contributing to
the market growth include the increasing
penetration of healthcare insurance and the
rising trend of medical tourism on the global
level. View Full Report with TOC List of
Figure https//www.imarcgroup.com/oncology-inject
ables-market
5
Report Description and Highlights
Report Description
Market Summary Breakup by Molecule Type
Small Molecule Large Molecule Breaku
p by Product Type Chemotherapy
Monoclonal Antibodies Cytokines
Peptide Hormones Breakup by Indication
Lung Cancer Breast Cancer
Colorectal Cancer Prostate Cancer
Stomach Cancer Liver Cancer
Esophagus Cancer

6
Report Description and Highlights
Report Description
Cervical Cancer Others Break
up by Branded/Generics Branded
Generics Breakup by Distribution Channel
Retail Pharmacies Hospital Pha
rmacies Online Pharmacies Breakup by
Region North America
United States Canada A
sia Pacific China
Japan India

7
Report Description and Highlights
Report Description
South Korea Au
stralia Indonesia
Others Europe Germ
any France Uni
ted Kingdom Italy
Spain Russia
Others Latin America
Brazil Mexico
Others Middle East and A
frica Turkey S
audi Arabia Others

8
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
11

Contact Us